AQUINOX PHARMACEUTICALS (USA) INC — Form D
AQUINOX PHARMACEUTICALS (USA) INC of RICHMOND, A1, a company, filed a Form D exempt-offering notice with the SEC on 2011-09-26. The offering totals $3.5M, of which $3.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2011-09-26
- Form: D
- Accession: 0001140361-11-046939
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $3.5M
- Amount sold: $3.5M
- Investors: 6
- Date of first sale: 2011-09-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-166388
Issuer
- Name: AQUINOX PHARMACEUTICALS (USA) INC
- CIK: 0001404644
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 5600 PARKWOOD WAY, SUITE 430, RICHMOND, A1, V6V 2M2
- Phone: 604-629-9223
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| Kenneth J Galbraith | Director | Richmond, A1 |
| Frank J Holler | Director | Richmond, A1 |
| ELAINE J JONES | Director | CAMBRIDGE, MA |
| Daniel J Levitt | Director | Richmond, A1 |
| David J Main | Director | Richmond, A1 |
| Asish J Xavier | Director | Richmond, A1 |
| Kamran J Alam | Executive Officer | Richmond, A1 |
| David J Main | Executive Officer | Richmond, A1 |
| David Main | Director | Vancouver, A1 |
| David Main | Executive Officer | Vancouver, A1 |
| Asish Xavier | Director | South San Francisco, CA |
| Kenneth Galbraith | Director | Vancouver, A1 |
| Elaine Jones | Director | SOUTH SAN FRANCISCO, CA |
| Daniel Levitt | Director | Los Altos, CA |
| Kamran Alam | Executive Officer | Richmond, A1 |
| David J Main | Promoter | Richmond, A1 |
| Frank H Holler | Director | Vancouver, A1 |
| Kenneth H Galbraith | Director | Vancouver, A1 |
| Elaine H Jones | Director | New York, NY |
| Asish H Xavier | Director | New Brunswick, NJ |
| Daniel H Levitt | Director | Richmond, A1 |
| Stephen H Majlath | Executive Officer | Richmond, A1 |
| Kevin H Leslie | Director | Vancouver, A1 |
Other filings by this issuer (4)
More